Intrasense — M&A Activity 2017

Oct 18, 2017

Montpellier,October 18, 2017, 17:45 pm

Intrasense (FR0011179886 - ALINS), specialist in medical imaging solutions, and CGTR, leading player in teleradiology, announced they have just signed a partnership agreement, during the French Journées Francophones de Radiologie tradeshow in Paris, last week-end.

Created in 2008, the Compagnie Générale de Télé-Radiologie (CGTR) develops with 280 physicians a model of teleradiology valuing proximity, quality and ethics as top priorities of CGTR network.

Disseminating Myrian® and its imaging applications designed by Intrasense, CGTR provides to radiologists of the network expert imaging applications, including some dedicated to cancer and vascular pathologies. These solutions are also already adopted by several regional hospital groups.

Pragmatic response to crucial challenges of the sector – medical demography, medical desertification, team cooperation, training, new practices remotely – telemedicine appears today as a major driver to improve the patient's healthcare.

Natively hosted in the BIC (Business Innovation Center) of Montpellier Métropole, Intrasense and CGTR conclude today a key partnership agreement, that Ms. Chantal Marion, Vice-president of Montpellier Méditerranée Métropole and Delegate to economic development, appreciates: « We are very pleased of such partnership initiatives, that the Montpellierian Metropole actively encourages. ».

« We set ourselves obligations to provide the specific means of medical field, which involves the equipment of teleradiologists in CGTR network: quality control, medical screen or imaging software must be approved for this diagnosis activity. Myrian® totally fulfils these obligations. » comments Yann Hetmaniak, co-founder and President of CGTR.

"We are pleased to announce our partnership agreement with CGTR in order to share our respective areas of expertise and provide synergies serving telemedicine," concludes Stéphane Chemouny, Chairman and CEO of Intrasense.

Founded in 2004, Intrasense develops and markets a unique medical device called Myrian®, a software platform that makes diagnosis, decision-making and therapeutic follow-up easier and much more secure. Thanks to Myrian®, more than 800 health institutions spread over 40 countries uses this unique and integrated platform supporting all types of imaging modalities (MRI, scanner…). Enriched with expert clinical modules dedicated to specific pathologies, Myrian® also provides a universal image treatment solution that can be fully integrated in any health information system. Intrasense includes 45 employees among which 20 are dedicated to Research & Development. Intrasense which has been labelled 'innovative company' by the BPI has invested more than 9 million euros in Research & Development since its creation.

For more information please visit www.intrasense.fr/.

The Compagnie Générale de Télé Radiologie, specialist in telemedicine for 10 years, based in Montpellier, innovates to improve access of the patient to healthcare. The CGTR is headed by physicians with the ambition to assist numeric evolutions and support a clinical telemedicine « à la française »: based on proximity, medical and organizational expertise. Convinced that exercise of telemedicine does not change ethics at all, its vocation is proposing services safely, for patients and healthcare professionals, and establish a climate of trust between actors, to secure patient healthcare. A network of more than 280 professionals, committed in an innovative and ethical approach.

For more information, please visit http://www.cgtr.fr.

Intrasense Stéphane Chemouny Chairman and Chief Executive Officer Président Christophe Lamboeuf Deputy Managing Director Tel: 01 48 04 32 83 investor@intrasense.fr

NewCap Investor Relations and Financial Communication Valentine Brouchot Pierre Laurent Tel: 01 44 71 94 96 intrasense@newcap.eu